Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TOI The Oncology Institute, Inc. Common Stock
$2.87 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TOI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 280.4M
Enterprise value 366.2M
Trailing PE -4.0211267874274
Forward PE -18.4375
PEG Ratio 0.18095070543424
Enterprise to EBITDA -10.743
Enterprise to revenue 0.794
Price to book MRQ -22.673174783623
Price to sales TTM 0.62950194

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 461.0M
EBITDA -34086000
Diluted EPS TTM -0.64
Total Cash (MRQ) 27.7M
Current ratio (MRQ) 1.679
Operating Cash Flow (TTM) -23634000

TOI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TOI News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.